Overcoming challenges in sustaining newborn screening in low-middle-income countries: the Philippine newborn screening system

Carmencita D. Padilla, Michelle E. Abadingo, Katherine V. Munda, B. Therrell
{"title":"Overcoming challenges in sustaining newborn screening in low-middle-income countries: the Philippine newborn screening system","authors":"Carmencita D. Padilla, Michelle E. Abadingo, Katherine V. Munda, B. Therrell","doi":"10.20517/rdodj.2023.38","DOIUrl":null,"url":null,"abstract":"Newborn screening (NBS) was introduced in the Philippines in 1996, and the Newborn Screening Act of 2004 mandated its provision to all Filipino newborns. The program initially covered five conditions and has expanded to the current panel of 29 conditions. This report focuses on the steps taken for successful NBS implementation and the challenges that must be overcome to make NBS sustainable. While often considered a public health program, NBS is really a system of interacting parts that must be carefully considered and planned prior to embarking on their implementation. The basic challenges are the same in both high-income and low-middle-income countries (LMICs), but they are more difficult to overcome in LMICs. In addition to the technical aspects of screening, including supplies and maintenance, considerations must include human resources, professional and public education, and government support. Challenges may occur at any point in implementation and continuation, and it is important to learn from the experiences of others in order to make the process more efficient. Here, we report on the experiences in one LMIC, the Philippines, in creating and sustaining a NBS system so that others may gain from these experiences.","PeriodicalId":74638,"journal":{"name":"Rare disease and orphan drugs journal","volume":"16 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rare disease and orphan drugs journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20517/rdodj.2023.38","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Newborn screening (NBS) was introduced in the Philippines in 1996, and the Newborn Screening Act of 2004 mandated its provision to all Filipino newborns. The program initially covered five conditions and has expanded to the current panel of 29 conditions. This report focuses on the steps taken for successful NBS implementation and the challenges that must be overcome to make NBS sustainable. While often considered a public health program, NBS is really a system of interacting parts that must be carefully considered and planned prior to embarking on their implementation. The basic challenges are the same in both high-income and low-middle-income countries (LMICs), but they are more difficult to overcome in LMICs. In addition to the technical aspects of screening, including supplies and maintenance, considerations must include human resources, professional and public education, and government support. Challenges may occur at any point in implementation and continuation, and it is important to learn from the experiences of others in order to make the process more efficient. Here, we report on the experiences in one LMIC, the Philippines, in creating and sustaining a NBS system so that others may gain from these experiences.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
克服挑战,在中低收入国家持续开展新生儿筛查:菲律宾的新生儿筛查系统
菲律宾于 1996 年引入新生儿筛查(NBS),2004 年的《新生儿筛查法》规定所有菲律宾新生儿都必须接受新生儿筛查。该计划最初涵盖五种疾病,后来扩展到目前的 29 种疾病。本报告重点介绍了成功实施新生儿筛查所采取的步骤,以及为使新生儿筛查可持续发展而必须克服的挑战。虽然国家健康调查通常被认为是一项公共卫生计划,但它实际上是一个由相互影响的部分组成的系统,在开始实施之前必须仔细考虑和规划。高收入国家和中低收入国家(LMICs)面临的基本挑战是相同的,但在中低收入国家更难克服。除了筛查的技术方面(包括供应和维护),还必须考虑人力资源、专业和公共教育以及政府支持。在实施和延续的过程中,任何时候都可能遇到挑战,因此必须借鉴其他国家的经验,使筛查过程更加高效。在此,我们将报告一个低收入国家(菲律宾)在创建和维持国家统计系统方面的经验,以便其他国家可以从中获益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Fabry nephropathy: a treatable cause of chronic kidney disease Gene therapy for Dravet syndrome: promises and impact on disease trigger and secondary modifications Neuropathy and pain in Fabry disease The division of rare diseases research innovation at the national center for advancing translational sciences, NIH: mission, history, and current research activities Long-term treatment with insulin-like growth factor-1 in Phelan-McDermid syndrome: a case report
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1